4-hydroxyphenyl 2-methylphenyl ketone | 52981-01-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-hydroxyphenyl 2-methylphenyl ketone
• 英文别名: (4-hydroxyphenyl)(o-tolyl)methanone；4-(o-Toluoyl)-phenol；4'-hydroxy-2-methyl-benzophenone；4'-Hydroxy-2-methyl-benzophenon；(4-Hydroxyphenyl)(2-methylphenyl)methanone；(4-hydroxyphenyl)-(2-methylphenyl)methanone
• CAS: 52981-01-8
• 化学式: C₁₄H₁₂O₂
• 分子量: 212.248
• InChiKey: PYLPYSHXUTVYCV-UHFFFAOYSA-N

物化性质

• 熔点：
  96°C

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2914501900

反应信息

• 作为反应物：
  描述：

  4-hydroxyphenyl 2-methylphenyl ketone 在 水 、 potassium carbonate 、 三乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 lithium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 6.0h， 生成 2-(4-(2-methylbenzoyl)phenoxy)-N-(pyridin-3-yl)acetamide
  参考文献：
  名称：

  二苯甲酮类化合物及其制备方法和应用

  摘要：

  本申请提供了一种二苯甲酮类化合物或其药学上可接受的盐，其结构如式I所示： 其中，X为‑(C＝O)‑NH‑或‑NH‑(C＝O)‑；n为1‑10的整数；R1、R2、R3分别表示一个或多个取代基，多个取代基可相同或不同，R1、R2、R3各自独立地选自氢、卤素、C1‑5烷基、C1‑5烷氧基、羟基、硝基、氰基和氨基中的一个或多个。本发明的化合物能够调控Kv11.1通道，恢复或逆转阿司咪唑对Kv11.1通道的抑制作用，降低阿司咪唑的心脏毒性以及具有缓解获得性LQTS的药学活性，是治疗获得性LQTS的潜在药物。

  公开号：

  CN115611805A
• 作为产物：
  描述：

  (4-甲氧基苯基)(2-甲基苯基)甲酮 在 aluminum (III) chloride 作用下， 以 甲苯 为溶剂， 以1.91 g的产率得到4-hydroxyphenyl 2-methylphenyl ketone
  参考文献：
  名称：

  二苯甲酮类化合物及其制备方法和应用

  摘要：

  本申请提供了一种二苯甲酮类化合物或其药学上可接受的盐，其结构如式I所示： 其中，X为‑(C＝O)‑NH‑或‑NH‑(C＝O)‑；n为1‑10的整数；R1、R2、R3分别表示一个或多个取代基，多个取代基可相同或不同，R1、R2、R3各自独立地选自氢、卤素、C1‑5烷基、C1‑5烷氧基、羟基、硝基、氰基和氨基中的一个或多个。本发明的化合物能够调控Kv11.1通道，恢复或逆转阿司咪唑对Kv11.1通道的抑制作用，降低阿司咪唑的心脏毒性以及具有缓解获得性LQTS的药学活性，是治疗获得性LQTS的潜在药物。

  公开号：

  CN115611805A

文献信息

• Quinoline and quinazoline derivatives inhibiting platelet-derived growth
  申请人：Kirin Beer Kabushiki Kaisha

  公开号：US06143764A1

  公开（公告）日：2000-11-07

  The present invention relates to novel quinoline derivatives and quinazoline derivatives represented by the following formula (I): ##STR1## [wherein R.sub.1 and R.sub.2 are each independently H or C.sub.1 -C.sub.4 -alkyl, or R.sub.1 and R.sub.2 together form C.sub.1 -C.sub.3 -alkylene, X is O, S or CH.sub.2, W is CH or N, and Q is a substituted aryl group or substituted heteroaryl group] and their pharmaceutically acceptable salts, having platelet-derived growth factor receptor autophosphorylation inhibitory activity, to pharmaceutical compositions containing these compounds, and to methods for the treatment of diseases associated with abnormal cell growth such as tumors.

  本发明涉及由以下式（I）表示的新型喹啉衍生物和喹唑啉衍生物：[其中R.sub.1和R.sub.2分别独立地为H或C.sub.1 -C.sub.4 -烷基，或R.sub.1和R.sub.2一起形成C.sub.1 -C.sub.3 -烷基，X为O、S或CH.sub.2，W为CH或N，Q为取代芳基或取代杂芳基]及其在药学上可接受的盐，具有血小板源性生长因子受体自磷酸化抑制活性，用于含有这些化合物的药物组合物，以及用于治疗与异常细胞生长（如肿瘤）相关的疾病的方法。
• Visible Light Copper Photoredox-Catalyzed Aerobic Oxidative Coupling of Phenols and Terminal Alkynes: Regioselective Synthesis of Functionalized Ketones via C≡C Triple Bond Cleavage
  作者：Arunachalam Sagadevan、Vaibhav Pramod Charpe、Ayyakkannu Ragupathi、Kuo Chu Hwang

  DOI：10.1021/jacs.6b13113

  日期：2017.3.1

  Direct oxidative coupling of phenols and terminal alkynes was achieved at room temperature by a visible-light-mediated copper-catalyzed photoredox process. This method allows regioselective synthesis of hydroxyl-functionalized aryl and alkyl ketones from simple phenols and phenylacetylene via C≡C triple bond cleavage. 47 examples were presented. From a synthetic perspective, this protocol offers an

  通过可见光介导的铜催化光氧化还原过程，在室温下实现了酚类和末端炔烃的直接氧化偶联。该方法允许通过 C≡C 三键断裂从简单的苯酚和苯乙炔区域选择性合成羟基官能化的芳基酮和烷基酮。展示了 47 个例子。从合成的角度来看，该协议为制备药物（如匹托苯和非诺贝特）提供了一种有效的合成途径。
• COMPOUNDS WITH ACTIVITY AT ESTROGEN RECEPTORS
  申请人：OLSSON Roger

  公开号：US20120088825A1

  公开（公告）日：2012-04-12

  Disclosed herein are compounds of Formula I as disclosed herein, methods of modulating the activity of an estrogen receptor and methods of treating a disorder associated with estrogen receptors.

  本文披露了I式化合物，调节雌激素受体活性的方法以及治疗与雌激素受体相关的疾病的方法。
• Light-Driven Carboxylation of <i>o</i>-Alkylphenyl Ketones with CO₂
  作者：Yusuke Masuda、Naoki Ishida、Masahiro Murakami

  DOI：10.1021/jacs.5b10032

  日期：2015.11.11

  o-Alkylphenyl ketones undergo a C-C bond forming carboxylation reaction with CO2 simply upon irradiation with UV light or even solar light. The reaction presents a clean process exploiting light energy as the driving force for carboxylation of organic molecules with CO2.
• Synthesis and structure–activity relationship for new series of 4-Phenoxyquinoline derivatives as specific inhibitors of platelet-derived growth factor receptor tyrosine kinase
  作者：Kazuo Kubo、Shin-ichi Ohyama、Toshiyuki Shimizu、Atsuya Takami、Hideko Murooka、Tsuyoshi Nishitoba、Shinichiro Kato、Mikio Yagi、Yoshiko Kobayashi、Noriko Iinuma、Toshiyuki Isoe、Kazuhide Nakamura、Hiroshi Iijima、Tatsushi Osawa、Toshio Izawa

  DOI：10.1016/j.bmc.2003.08.020

  日期：2003.11

  We discovered a new series of 4-phenoxyquinoline derivatives as potent and selective inhibitors of the platelet-derived growth factor receptor (PDGFr) tyrosine kinase. We researched the highly potent and selective inhibitors on the basis of both PDGFr and epidermal growth factor receptor (EGFr) inhibitory activity. First, we found a compound, Ki6783 (1), which inhibited PDGFr autophosphorylation at 0.13 muM, but it did not inhibit EGFr autophosphorylation at 100 muM. After extensive explorations, we found the two desired compounds, Ki6896 (2) and Ki6945 (3), which are substituted by benzoyl and benzamide at the 4-position of the phenoxy group on 4-phenoxyquinoline, respectively. These inhibitory activities were 0.31 and 0.050 muM, respectively, but neither of them inhibited EGFr autophosphorylation at 100 M. We further investigated the profile of both compounds toward various tyrosine and serine/threonine kinases. The three compounds specifically inhibited PDGFr rather than the other kinases. (C) 2003 Elsevier Ltd. All rights reserved.